...
首页> 外文期刊>癌と化学療法 >A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1
【24h】

A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1

机译:一种先进的侧壁口咽癌癌,表明TS-1的化疗完全反应

获取原文
获取原文并翻译 | 示例

摘要

We report a recent case of squamous cell carcinoma originating in the right tonsil, with metastasis to the right superior cervical lymph nodes (T3N2bM0: stage IVA). Chemo-radiotherapy was administered as first-line therapy; and adjuvant chemotherapy with TS-1 was applied during the subsequent 4-week period for the treatment of the residual tumor in the neck. In this patient (female, 61 years old), the primary tonsillar tumor showed a complete response to the first-line therapy, however, the metastatic lesions in the cervical lymph nodes persisted, although the nodes also decreased markedly in size. Subsequent chemotherapy with TS-1 (80 mg/day) given for a 4-week period resulted in complete disappearance of the residual malignancy (CR), as determined by palpation and diagnostic imaging. No serious adverse events occurred during the therapy. Surgical treatment in patients with advanced head and neck cancer often results in a diminished quality of life. Although further accumulation of cases is necessary,TS-1, which allows oral chemotherapy on an outpatient basis, would seem to be a useful drug for adjuvant chemotherapy following radical irradiation in patients with advanced head and neck cancer.
机译:我们报告了近期在右扁桃体中的鳞状细胞癌的案例,转移到右上颈淋巴结(T3N2BM0:阶段IVA)。化学放射疗法被赋予一线治疗;在随后的4周内使用TS-1进行佐剂化疗,用于治疗颈部残留肿瘤。在该患者(女性,61岁)中,初级扁桃体肿瘤显示出对第一线疗法的完全反应,然而,宫颈淋巴结中的转移性病变持续存在,尽管节点也明显降低。随后的化学疗法为4周的TS-1(80mg /天)导致残留恶性肿瘤(Cr)的完全消失,如触诊和诊断成像所确定的。治疗期间没有发生严重不良事件。头部和颈部癌症患者的手术治疗往往导致生命质量减少。虽然案件的进一步积累是必要的,但是TS-1,允许口腔化疗的外部化疗,似乎是辅助化疗后辅助化疗的有用药物,其在先进的头部和颈部癌症患者的激进辐照后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号